José L. Díez‐Martín

Hospital General Universitario Gregorio Marañón — Spain

Medicine · Health Sciences

39h-index5.7kcitations380works5.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(168), Acute Myeloid Leukemia Research(81), Acute Lymphoblastic Leukemia research(67), Lymphoma Diagnosis and Treatment(53), Viral-associated cancers and disorders(43)

Publications379 total

Long‐Term Clinical Outcomes After Autologous Hematopoietic Stem Cell Transplantation in 49 Individuals Living With HIV (PLWH) and Affected by High‐Risk or Relapsed Lymphoma: A European Experience of Continued Relevance for PLWH
Journal of Medical Virology·2025Open Access
Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA-matched stem-cell transplantation for acute myeloid leukemia
Leukemia·2024· 6 citedOpen Access
Identification of predictive models including polymorphisms in cytokines genes and clinical variables associated with post-transplant complications after identical HLA-allogeneic stem cell transplantation
Frontiers in Immunology·2024· 2 citedOpen Access
Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study
The Lancet HIV·2024· 18 citedOpen Access
Advantages of high cell concentration prior to cryopreservation of initial leukapheresis in CAR-T cell therapy.
PubMed·2024· 4 citedOpen Access
Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA- matched stem-cell transplantation for AML
2024· 1 citedOpen Access
Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients
Transplantation and Cellular Therapy·2024· 10 cited
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
Transplantation and Cellular Therapy·2023· 12 cited
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplants for Patients with Hodgkin disease: A Comparative Study of the LWP EBMT
Blood·2023
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
Cancers·2023· 6 citedOpen Access
Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia—a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
Bone Marrow Transplantation·2023· 9 citedOpen Access
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide
Annals of Hematology·2023· 12 cited
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post‐transplant cyclophosphamide in AML in first complete remission
British Journal of Haematology·2023· 3 citedOpen Access
Cell-Free DNA Dynamic Concentration and Other Variables Are Predictors of Early Progression after Chimeric Antigen Receptor T Cell Therapy in Patients with Diffuse Large B Cell Lymphoma
Transplantation and Cellular Therapy·2023· 6 citedOpen Access
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study
Cancers·2023· 20 citedOpen Access
Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis
HemaSphere·2023· 9 citedOpen Access
Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing
Cancers·2023Open Access
Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukemia - a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
2023Open Access
Non-T Depleted Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Secondary Versus De Novo AML: A Study from the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Transplantation and Cellular Therapy·2023· 1 citedOpen Access
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas
Transplantation and Cellular Therapy·2022· 21 citedOpen Access
page 1 of 19Next →

Frequent Co-authors

Mi Kwon(15), Ismael Buño(14), Pascual Balsalobre(13), David Serrano(12), Anna Sureda(10), Carolina Martínez‐Laperche(10), Didier Blaise(9), Yener Koç(8), Myriam Labopin(7), Fabio Ciceri(7), Mohamad Mohty(7), Jorge Gayoso(7), Javier Anguita(7), Arnon Nagler(6), Jaime Sanz(6), Josep‐María Ribera(5), Gabriela Rodríguez‐Macías(5), Mariana Bastos‐Oreiro(5), Rebeca Bailén(5), Bipin N. Savani(5)